Try our beta test site
18 studies found for:    Open Studies | "Hemorrhagic Fever, Ebola"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hemorrhagic Fever, Ebola"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo
2 Recruiting Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Placebo
3 Recruiting Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Placebo
4 Recruiting A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo
Conditions: Ebola;   Ebola Zaire
Interventions: Biological: cAd3-EBO Z at 1 x 10^10 vp;   Biological: cAd3-EBO Z at 2.5 x 10^10 vp;   Biological: cAd3-EBO Z at 5 x 10^10 vp;   Biological: 4.4x10^8 TCID50s MVA-BN® Filo;   Biological: 2.2x10^8 TCID50s MVA-BN® Filo;   Biological: 4.4 x 10^7 TCID50s MVA-BN® Filo
5 Not yet recruiting Partnership for Research on Ebola VACcinations
Condition: Ebola Virus Disease
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: rVSVΔG-ZEBOV-GP;   Biological: Placebo;   Biological: rVSV boost
6 Recruiting Open Study of the Duration of Immunity After Vaccination With GamEvac
Condition: Hemorrhagic Fever, Ebola
Intervention: Procedure: blood sampling collection
7 Not yet recruiting African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
Condition: Ebola
Interventions: Biological: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine;   Other: Saline
8 Recruiting Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
Condition: Ebola Virus Survivor
Intervention: Drug: Favipiravir
9 Recruiting GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
Condition: Persistent Ebola Virus
Interventions: Drug: GS-5734;   Other: Placebo Comparator
10 Recruiting Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
Condition: Ebola Virus Disease
Intervention:
11 Recruiting Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
Condition: Ebola Hemorrhagic Fever
Intervention: Procedure: blood sampling collection
12 Not yet recruiting International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi
Conditions: Ebola Virus Disease;   Prevention
Interventions: Biological: GamEvac-Combi (vaccine);   Biological: Placebo
13 Not yet recruiting MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Conditions: Ebola Disease;   Marburg Disease
Interventions: Biological: Ad26 Zaire Ebola Vaccine;   Biological: MVA Multi-Filo Ebola Vaccine
14 Recruiting Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers
Condition: Ebola Vaccine
Interventions: Biological: INO-4201;   Biological: INO-4202;   Biological: INO-4212;   Biological: INO-4212 + INO-9012;   Biological: INO-4201 + INO-9012
15 Recruiting Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2
Condition: Healthy
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Menveo;   Biological: Placebo
16 Recruiting A Study to Assess Safety Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults
Condition: Healthy
Interventions: Biological: MVA-BN-Filo;   Biological: Ad26.ZEBOV;   Biological: Placebo
17 Not yet recruiting Immune Durability After VSV-EBOV Vaccination
Conditions: Immune Response;   Vaccination;   Durability
Intervention:
18 Recruiting Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers
Condition: Healthy
Intervention: Drug: ZMAPP

Study has passed its completion date and status has not been verified in more than two years.